Art
J-GLOBAL ID:201802284986032509   Reference number:18A1117828

Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update

免疫チェックポイント阻害剤を用いた治療から生じる免疫関連有害事象の最適な管理:レビューおよび最新情報
Author (2):
Material:
Volume: 23  Issue:Page: 410-420  Publication year: Jun. 2018 
JST Material Number: L3966A  ISSN: 1341-9625  Document type: Article
Article type: 文献レビュー  Country of issue: Germany, Federal Republic of (DEU)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1117828&from=J-GLOBAL&jstjournalNo=L3966A") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Immunotherapy for tumors  ,  Clinical application of antitumor(=antineoplastic)drugs 
Reference (62):
  • Mellman I, Coukos G, Dranoff G (2011) Cancer immunotherapy comes of age. Nature 480:480-489
  • Hodi FS, O’Day SJ, McDermott DF et al (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363(8):711-723
  • Robert C, Long GV, Brady B et al (2015) Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 372(4):320-330
  • Larkin J, Chiarion-Sileni V, Gonzalez R et al (2015) Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl J Med 373(1):23-34
  • Brahmer J, Reckamp KL, Baas P et al (2015) Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med 373(2):123-135
more...
Terms in the title (5):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page